Synthivan Tablet (30’s) is a combination medication that contains Atazanavir (300mg) and Ritonavir (100mg), primarily used in the management of HIV-1 infection. This powerful antiretroviral therapy works by inhibiting the replication of the virus, thereby helping to control the viral load in the body. Atazanavir is a protease inhibitor that targets the HIV protease enzyme, while Ritonavir acts as a booster, enhancing the effectiveness of Atazanavir by slowing its metabolism. Together, they form a potent regimen that aids in improving the immune system’s function and reducing the risk of HIV-related complications. Synthivan is typically prescribed as part of a comprehensive treatment plan that may include other antiretroviral agents, and it is essential for patients to adhere to their prescribed regimen to achieve optimal results.

Atazor-R 300mg/100mg Tablet is a combination medication that contains Atazanavir (300mg) and Ritonavir (100mg), primarily used in the management of HIV-1 infection. This powerful antiretroviral therapy works by inhibiting the replication of the virus, thereby helping to control the viral load in the body. Atazanavir is a protease inhibitor that targets the HIV protease enzyme, while Ritonavir acts as a booster, enhancing the effectiveness of Atazanavir by increasing its plasma concentration. The tablet is typically prescribed as part of a comprehensive treatment regimen for individuals diagnosed with HIV, aiming to improve their immune function and reduce the risk of HIV-related complications. With a convenient packaging of 30 tablets, Atazor-R is designed for daily use, making it easier for patients to adhere to their treatment plans.